Adaptive Reuse Is Moving, But the Capital Stack Is Getting More Specific
The adaptive reuse and conversion market is entering a more disciplined phase in 2026. Activity has not slowed, but it has stratified. Office-to-multifamily continues to generate the most headline volume, while office-to-life-science conversions are concentrating in a tighter cluster of gateway and innovation markets. Retail-to-self-storage is quietly proving itself as one of the more executable plays for sponsors who can move quickly on distressed anchored product. Across all three conversion types, the common thread this week is the same: the deals getting done are the ones where sponsors arrived with a forward take-out structure already sketched in before construction financing was even quoted.
That sequencing matters more than it did two years ago. Specialty debt funds pricing conversion bridge product are stress-testing exit assumptions at the term sheet stage, and lenders who previously took a more accommodating view of speculative lease-up timelines are now requiring borrowers to articulate a credible permanent financing path. If you are in predevelopment on a conversion asset right now, the question your capital partner is going to ask first is not about basis. It is about who is taking you out and under what conditions.
Where the Conversion Debt Markets Are Pricing Today
Specialty debt funds active in the conversion and adaptive reuse space are broadly quoting bridge product in spread ranges that reflect both the complexity premium of conversion collateral and the continued dislocation in office valuations. All-in pricing on office-to-multifamily conversion bridge loans has remained elevated relative to ground-up multifamily construction, with spread premiums that tend to reflect the additional entitlement, structural, and leasing risk embedded in the asset class. Loan-to-cost tolerances have tightened somewhat from the more aggressive postures of 2023 and 2024, and sponsors should be underwriting to lower proceeds relative to total project cost than they may have modeled in earlier deal cycles.
Life science conversion debt is in a more bifurcated place. Deals in core life science clusters with credible pre-leasing or letters of intent from institutional tenants are still attracting interest from specialty lenders and select life insurance company programs. Deals without that pre-leasing anchor are finding the market considerably thinner, and a number of those projects are either shelved or being repositioned toward a different end use. Mission CDFIs with life science or biomedical workforce mandates remain a useful complementary source for a narrow set of projects in qualified census tracts or with workforce housing components, but deal terms and deployment timelines vary widely by institution.
Retail-to-self-storage has attracted a more consistent lender universe than many sponsors expected. The conversion cost basis is typically lower than office plays, the operating stabilization timeline is shorter, and the demand fundamentals in suburban and secondary markets have remained durable. Bridge lenders covering this product type are pricing it closer to traditional self-storage development debt, though they are applying additional scrutiny to zoning and entitlement risk on the retail shell. Sponsors who have already cleared those hurdles are finding the debt market more receptive than the broader conversation about retail distress might suggest.
Forward Take-Out Structuring: What Lenders Are Expecting Now
The structural conversation that is dominating conversion deal negotiations right now is forward take-out commitment timing. Agency execution for office-to-multifamily conversions that meet affordability thresholds has remained an important part of the exit equation, and sponsors who can demonstrate a plausible path to agency-eligible stabilization are still getting constructive engagement from the bridge lender community. The nuance is in the conditions. Agency lenders are tightening their own underwriting around conversion collateral, and assumptions about rent growth, vacancy, and operating expense ratios that worked in a 2023 model are getting renegotiated in 2025 and 2026 applications.
For deals that will not qualify for agency take-out, sponsors should be building their capital stack with a CMBS or life company permanent as the baseline exit, and those conversations should start no later than the construction financing close. Forward rate lock products and rate cap structuring are still available for sponsors with sufficient deal quality, but execution windows are narrower than they were, and lenders are being more selective about which conversion assets they want to own at stabilization. Floating rate permanent products with extension options remain a useful tool for sponsors who need flexibility on their stabilization timeline, but that flexibility now comes with more meaningful rate and fee exposure than sponsors may be accustomed to underwriting.
Positioning Your Deal for the Current Round
The sponsors winning capital allocation in this environment are not necessarily the ones with the lowest basis or the most experienced track record, though both matter. They are the ones arriving at the lender conversation with a coherent narrative that connects acquisition or land cost, conversion budget, stabilization timeline, and a specific take-out structure. Ambiguity about the exit is the fastest way to lose a term sheet in this market.
If you have a conversion or adaptive reuse deal in predevelopment, entitlement, or early capital stack formation, the window to structure intelligently is now, before you are competing for a tightening allocation of specialty debt fund capital later in the year. CLS CRE works with developers, operating partners, and owners across the full spectrum of conversion product types. Reach out to our team to talk through your deal, your capital stack, and how to position for the current lending environment.
Trevor Damyan is a commercial mortgage broker at Commercial Lending Solutions with a background in structured finance at CBRE and Marcus and Millichap Capital Corporation. He specializes in bridge loans, construction financing, SBA programs, DSCR loans, and complex capital structures for investors and developers across all 50 states.
View full profile →